Gasco M - Search Results

1

Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.

Gasco M, Bell AK, Heath V, Sullivan A, Smith P, Hiller L, Yulug I, Numico G, Merlano M, Farrell PJ, Tavassoli M, Gusterson B, Crook T. Gasco M, et al. Cancer Res. 2002 Apr 1;62(7):2072-6. Cancer Res. 2002. PMID: 11929827

2

TP53 mutations in familial breast cancer: functional aspects.

Gasco M, Yulug IG, Crook T. Gasco M, et al. Hum Mutat. 2003 Mar;21(3):301-6. doi: 10.1002/humu.10173. Hum Mutat. 2003. PMID: 12619116 Review.

3

p53 family members and chemoresistance in cancer: what we know and what we need to know.

Gasco M, Crook T. Gasco M, et al. Drug Resist Updat. 2003 Dec;6(6):323-8. doi: 10.1016/j.drup.2003.11.001. Drug Resist Updat. 2003. PMID: 14744496 Review.

4

Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.

Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, Gusterson B, Evans DJ, Crook T. Gasco M, et al. Oncogene. 2002 Mar 14;21(12):1876-81. doi: 10.1038/sj.onc.1205256. Oncogene. 2002. PMID: 11896620

5

Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus.

Brooks LA, Tidy JA, Gusterson B, Hiller L, O'Nions J, Gasco M, Marin MC, Farrell PJ, Kaelin WG Jr, Crook T. Brooks LA, et al. Among authors: gasco m. Cancer Res. 2000 Dec 15;60(24):6875-7. Cancer Res. 2000. PMID: 11156383

6

The p53 network in head and neck cancer.

Gasco M, Crook T. Gasco M, et al. Oral Oncol. 2003 Apr;39(3):222-31. doi: 10.1016/s1368-8375(02)00163-x. Oral Oncol. 2003. PMID: 12618194 Review.

7

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Among authors: gasco m. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

8

Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine.

Numico G, Garrone O, Dongiovanni V, Silvestris N, Colantonio I, Di Costanzo G, Granetto C, Occelli M, Fea E, Heouaine A, Gasco M, Merlano M. Numico G, et al. Among authors: gasco m. Cancer. 2005 Mar 1;103(5):994-9. doi: 10.1002/cncr.20893. Cancer. 2005. PMID: 15666321 Free article.

9

Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.

Smith P, Nicholson LJ, Syed N, Payne A, Hiller L, Garrone O, Occelli M, Gasco M, Crook T. Smith P, et al. Among authors: gasco m. Clin Cancer Res. 2007 Jul 15;13(14):4061-8. doi: 10.1158/1078-0432.CCR-06-3052. Clin Cancer Res. 2007. PMID: 17634530

10

The p53 pathway in breast cancer.

Gasco M, Shami S, Crook T. Gasco M, et al. Breast Cancer Res. 2002;4(2):70-6. doi: 10.1186/bcr426. Epub 2002 Feb 12. Breast Cancer Res. 2002. PMID: 11879567 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters